These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2242658)

  • 21. Administration of tobramycin and gentamicin by the intravenous route every 6 hr in patients with normal renal function.
    Setia U; Gross PA
    J Infect Dis; 1976 Aug; 134 Suppl():S125-9. PubMed ID: 972270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.
    Welch LP; Leader WG; Chandler MH
    Clin Pharm; 1993 Dec; 12(12):909-13. PubMed ID: 8137608
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of two infusion methods for pharmacokinetic monitoring of gentamicin.
    Nahata MC; Crist KD
    Ther Drug Monit; 1990 Mar; 12(2):150-3. PubMed ID: 2315972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and implementation of simplified aminoglycoside empiric dosing guidelines.
    Reesor Nimmo C; Mamdani F; Baker A; Jewesson P
    Pharmacotherapy; 1993; 13(4):408-14. PubMed ID: 8361871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
    Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
    Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis.
    Cornwell EE; Belzberg H; Berne TV; Kern JW; Henriques G; Asensio JA; Demetriades D
    South Med J; 1997 Jan; 90(1):33-6. PubMed ID: 9003820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoglycoside dosing in pediatric patients.
    Carlstedt BC; Uaamnuichai M; Day RB; Bowman L; Brater DC
    Ther Drug Monit; 1989; 11(1):38-43. PubMed ID: 2911852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.
    Etzel JV; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1992 Mar; 36(3):679-81. PubMed ID: 1622185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A reliable and cost-effective neonatal aminoglycoside administration system.
    Lopez AM; Keirns S; Wang H; Goldberg RN
    Neonatal Netw; 1989 Feb; 7(4):7-10. PubMed ID: 2492632
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of infusion systems on pharmacokinetic parameters of tobramycin in newborn infants.
    Nahata MC
    Chemotherapy; 1988; 34(5):361-6. PubMed ID: 3180903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycoside dosing in obese puerperal women.
    Gibbs RS; Blanco JD; Lipscomb KA
    Am J Obstet Gynecol; 1985 May; 152(1):89-90. PubMed ID: 3993717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Bayesian feedback method of aminoglycoside dosing.
    Burton ME; Brater DC; Chen PS; Day RB; Huber PJ; Vasko MR
    Clin Pharmacol Ther; 1985 Mar; 37(3):349-57. PubMed ID: 3971658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
    J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is tobramycin less nephrotoxic than gentamicin?
    Burkle WS
    Clin Pharm; 1986 Jun; 5(6):514-6. PubMed ID: 3522055
    [No Abstract]   [Full Text] [Related]  

  • 37. Once-daily versus pharmacokinetic dosing of aminoglycosides.
    Medicus-Bringa M; Ward G; Rice M
    Am J Med; 1997 Oct; 103(4):328-30. PubMed ID: 9382126
    [No Abstract]   [Full Text] [Related]  

  • 38. Aminoglycosides: another look at current and future roles in antimicrobial therapy.
    Murphy JE
    Pharmacotherapy; 1990; 10(3):217-23. PubMed ID: 2196537
    [No Abstract]   [Full Text] [Related]  

  • 39. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the levels of tobramycin and gentamicin in human serum and renal cortex and of changes in in vitro bacterial sensitivity.
    Faragó E; Guba T
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):199-203. PubMed ID: 3403098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.